{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "21252304", "DateCompleted": {"Year": "2011", "Month": "03", "Day": "23"}, "DateRevised": {"Year": "2023", "Month": "08", "Day": "07"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1073/pnas.1014792108"], "ArticleDate": [{"Year": "2011", "Month": "01", "Day": "20"}], "Journal": {"ISSN": "1091-6490", "JournalIssue": {"Volume": "108", "Issue": "5", "PubDate": {"Year": "2011", "Month": "Feb", "Day": "01"}}, "Title": "Proceedings of the National Academy of Sciences of the United States of America", "ISOAbbreviation": "Proc Natl Acad Sci U S A"}, "ArticleTitle": "Gastrin-releasing peptide blockade as a broad-spectrum anti-inflammatory therapy for asthma.", "Pagination": {"StartPage": "2100", "EndPage": "2105", "MedlinePgn": "2100-5"}, "Abstract": {"AbstractText": ["Gastrin-releasing peptide (GRP) is synthesized by pulmonary neuroendocrine cells in inflammatory lung diseases, such as bronchopulmonary dysplasia (BPD). Many BPD infants develop asthma, a serious disorder of intermittent airway obstruction. Despite extensive research, early mechanisms of asthma remain controversial. The incidence of asthma is growing, now affecting >300 million people worldwide. To test the hypothesis that GRP mediates asthma, we used two murine models: ozone exposure for air pollution-induced airway hyperreactivity (AHR), and ovalbumin (OVA)-induced allergic airway disease. BALB/c mice were given small molecule GRP blocking agent 77427, or GRP blocking antibody 2A11, before exposure to ozone or OVA challenge. In both models, GRP blockade abrogated AHR and bronchoalveolar lavage (BAL) macrophages and granulocytes, and decreased BAL cytokines implicated in asthma, including those typically derived from Th1 (e.g., IL-2, TNF\u03b1), Th2 (e.g., IL-5, IL-13), Th17 (IL-17), macrophages (e.g., MCP-1, IL-1), and neutrophils (KC = IL-8). Dexamethasone generally had smaller effects on all parameters. Macrophages, T cells, and neutrophils express GRP receptor (GRPR). GRP blockade diminished serine phosphorylation of GRPR with ozone or OVA. Thus, GRP mediates AHR and airway inflammation in mice, suggesting that GRP blockade is promising as a broad-spectrum therapeutic approach to treat and/or prevent asthma in humans."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA. shutang.zhou@duke.edu"}], "Identifier": [], "LastName": "Zhou", "ForeName": "Shutang", "Initials": "S"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Potts", "ForeName": "Erin N", "Initials": "EN"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Cuttitta", "ForeName": "Frank", "Initials": "F"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Foster", "ForeName": "W Michael", "Initials": "WM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Sunday", "ForeName": "Mary E", "Initials": "ME"}], "GrantList": [{"GrantID": "P01 AI081672", "Acronym": "AI", "Agency": "NIAID NIH HHS", "Country": "United States"}, {"GrantID": "R01 ES016347", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "ES016347", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "AI081672", "Acronym": "AI", "Agency": "NIAID NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't", "Validation Study", "Retracted Publication"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Proc Natl Acad Sci U S A", "NlmUniqueID": "7505876", "ISSNLinking": "0027-8424"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "80043-53-4", "NameOfSubstance": "Gastrin-Releasing Peptide"}], "CommentsCorrectionsList": [{"RefSource": "Proc Natl Acad Sci U S A. 2015 Apr 7;112(14):E1813. doi: 10.1073/pnas.1504672112", "PMID": "25825774"}, {"RefSource": "Fed Regist. 2019 Nov 7;84(216):60097-60098.", "PMID": "37547121"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Asthma"}, {"QualifierName": [], "DescriptorName": "Bronchoalveolar Lavage Fluid"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Gastrin-Releasing Peptide"}, {"QualifierName": [], "DescriptorName": "Immunohistochemistry"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred BALB C"}], "CoiStatement": "Conflict of interest statement: S.Z., E.N.P., W.M.F., and M.E.S. have submitted a patent application to the Duke Ventures office, but outside contacts have not yet been made."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Cotran RS, Kumar V, Collins T. Robbins' Pathologic Basis of Disease. 6th Ed. Philadelphia: Saunders; 1999."}, {"Citation": "Kim HY, DeKruyff RH, Umetsu DT. The many paths to asthma: Phenotype shaped by innate and adaptive immunity. Nat Immunol. 2010;11:577\u2013584.", "ArticleIdList": ["PMC3114595", "20562844"]}, {"Citation": "Beasley R. The burden of asthma with specific reference to the United States. J Allergy Clin Immunol. 2002;109(5 Suppl):S482\u2013S489.", "ArticleIdList": ["11994720"]}, {"Citation": "Gaga M, et al. ENFUMOSA Study Group Risk factors and characteristics associated with severe and difficult to treat asthma phenotype: An analysis of the ENFUMOSA group of patients based on the ECRHS questionnaire. Clin Exp Allergy. 2005;35:954\u2013959.", "ArticleIdList": ["16008684"]}, {"Citation": "Shore SA, Drazen JM. Beta-agonists and asthma: Too much of a good thing? J Clin Invest. 2003;112:495\u2013497.", "ArticleIdList": ["PMC171402", "12925688"]}, {"Citation": "Sunday ME, Yoder BA, Cuttitta F, Haley KJ, Emanuel RL. Bombesin-like peptide mediates lung injury in a baboon model of bronchopulmonary dysplasia. J Clin Invest. 1998;102:584\u2013594.", "ArticleIdList": ["PMC508919", "9691095"]}, {"Citation": "Ng DK, Lau WY, Lee SL. Pulmonary sequelae in long-term survivors of bronchopulmonary dysplasia. Pediatr Int. 2000;42:603\u2013607.", "ArticleIdList": ["11192514"]}, {"Citation": "Evans M, Palta M, Sadek M, Weinstein MR, Peters ME. Associations between family history of asthma, bronchopulmonary dysplasia, and childhood asthma in very low birth weight children. Am J Epidemiol. 1998;148:460\u2013466.", "ArticleIdList": ["9737558"]}, {"Citation": "Bai TR, Knight DA. Structural changes in the airways in asthma: Observations and consequences. Clin Sci (Lond) 2005;108:463\u2013477.", "ArticleIdList": ["15896192"]}, {"Citation": "Hamid Q, Tulic\u2019 MK, Liu MC, Moqbel R. Inflammatory cells in asthma: Mechanisms and implications for therapy. J Allergy Clin Immunol. 2003;111(1 Suppl):S5\u2013S12. discussion S12\u2013S17.", "ArticleIdList": ["12532083"]}, {"Citation": "Lilly CM. Diversity of asthma: Evolving concepts of pathophysiology and lessons from genetics. J Allergy Clin Immunol. 2005;115(4 Suppl):S526\u2013S531.", "ArticleIdList": ["15806035"]}, {"Citation": "Groneberg DA, Quarcoo D, Frossard N, Fischer A. Neurogenic mechanisms in bronchial inflammatory diseases. Allergy. 2004;59:1139\u20131152.", "ArticleIdList": ["15461593"]}, {"Citation": "Joos GF, Germonpre PR, Kips JC, Peleman RA, Pauwels RA. Sensory neuropeptides and the human lower airways: Present state and future directions. Eur Respir J. 1994;7:1161\u20131171.", "ArticleIdList": ["7925887"]}, {"Citation": "Chanez P, et al. Bronchial mucosal immunoreactivity of sensory neuropeptides in severe airway diseases. Am J Respir Crit Care Med. 1998;158:985\u2013990.", "ArticleIdList": ["9731035"]}, {"Citation": "Dusser DJ, Djokic TD, Borson DB, Nadel JA. Cigarette smoke induces bronchoconstrictor hyperresponsiveness to substance P and inactivates airway neutral endopeptidase in the guinea pig. Possible role of free radicals. J Clin Invest. 1989;84:900\u2013906.", "ArticleIdList": ["PMC329734", "2474576"]}, {"Citation": "Linnoila RI. Functional facets of the pulmonary neuroendocrine system. Lab Invest. 2006;86:425\u2013444.", "ArticleIdList": ["16568108"]}, {"Citation": "Wharton J, et al. Bombesin-like immunoreactivity in the lung. Nature. 1978;273:769\u2013770.", "ArticleIdList": ["351419"]}, {"Citation": "Sunday ME, Hua J, Dai HB, Nusrat A, Torday JS. Bombesin increases fetal lung growth and maturation in utero and in organ culture. Am J Respir Cell Mol Biol. 1990;3:199\u2013205.", "ArticleIdList": ["2390263"]}, {"Citation": "King KA, Torday JS, Sunday ME. Bombesin and [Leu8]phyllolitorin promote fetal mouse lung branching morphogenesis via a receptor-mediated mechanism. Proc Natl Acad Sci USA. 1995;92:4357\u20134361.", "ArticleIdList": ["PMC41943", "7753811"]}, {"Citation": "Subramaniam M, et al. Bombesin-like peptides modulate alveolarization and angiogenesis in bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2007;176:902\u2013912.", "ArticleIdList": ["PMC2048672", "17585105"]}, {"Citation": "Impicciatore M, Bertaccini G. The bronchoconstrictor action of the tetradecapeptide bombesin in the guinea-pig. J Pharm Pharmacol. 1973;25:872\u2013875.", "ArticleIdList": ["4149649"]}, {"Citation": "Lach E, Haddad EB, Gies JP. Contractile effect of bombesin on guinea pig lung in vitro: Involvement of gastrin-releasing peptide-preferring receptors. Am J Physiol. 1993;264:L80\u2013L86.", "ArticleIdList": ["8381599"]}, {"Citation": "Bousbaa H, Fleury-Feith J. Effects of a long-standing challenge on pulmonary neuroendocrine cells of actively sensitized guinea pigs. Am Rev Respir Dis. 1991;144:714\u2013717.", "ArticleIdList": ["1679982"]}, {"Citation": "Aguayo SM, et al. Brief report: Idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells and airways disease. N Engl J Med. 1992;327:1285\u20131288.", "ArticleIdList": ["1406819"]}, {"Citation": "Deterding RR, Pye C, Fan LL, Langston C. Persistent tachypnea of infancy is associated with neuroendocrine cell hyperplasia. Pediatr Pulmonol. 2005;40:157\u2013165.", "ArticleIdList": ["15965897"]}, {"Citation": "Cullen A, et al. Urine bombesin-like peptide elevation precedes clinical evidence of bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2002;165:1093\u20131097.", "ArticleIdList": ["11956050"]}, {"Citation": "Subramaniam M, et al. Bombesin-like peptides and mast cell responses: Relevance to bronchopulmonary dysplasia? Am J Respir Crit Care Med. 2003;168:601\u2013611.", "ArticleIdList": ["12807697"]}, {"Citation": "Rosen DM, et al. Accelerated thymic maturation and autoreactive T cells in bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2006;174:75\u201383.", "ArticleIdList": ["PMC2662921", "16574933"]}, {"Citation": "Del Rio M, De la Fuente M. Chemoattractrant capacity of bombesin, gastrin-releasing peptide and neuromedin C is mediated through PKC activation in murine peritoneal leucocytes. Peptides. 1994;49:185\u2013193.", "ArticleIdList": ["8140272"]}, {"Citation": "Yule KA, White SR. Migration of 3T3 and lung fibroblasts in response to calcitonin gene-related peptide and bombesin. Exp Lung Res. 1999;25:261\u2013273.", "ArticleIdList": ["10352955"]}, {"Citation": "Rozengurt E, Sinnett-Smith J. Bombesin stimulation of fibroblast mitogenesis: Specific receptors, signal transduction and early events. Philos Trans R Soc Lond B Biol Sci. 1990;327:209\u2013221.", "ArticleIdList": ["1969660"]}, {"Citation": "Cullen A, et al. Bombesin-like peptide (BLP) and BLP receptors in two different baboon models of bronchopulmonary dysplasia: Diversity in gene expression yet similarity in function. Peptides. 2000;21:1627\u20131638.", "ArticleIdList": ["11090916"]}, {"Citation": "Dozor AJ. The role of oxidative stress in the pathogenesis and treatment of asthma. Ann N Y Acad Sci. 2010;1203:133\u2013137.", "ArticleIdList": ["20716295"]}, {"Citation": "Savov JD, et al. Ozone-induced acute pulmonary injury in inbred mouse strains. Am J Respir Cell Mol Biol. 2004;31:69\u201377.", "ArticleIdList": ["14975936"]}, {"Citation": "Whitehead GS, Walker JK, Berman KG, Foster WM, Schwartz DA. Allergen-induced airway disease is mouse strain dependent. Am J Physiol Lung Cell Mol Physiol. 2003;285:L32\u2013L42.", "ArticleIdList": ["12626335"]}, {"Citation": "Shriver SP, et al. Sex-specific expression of gastrin-releasing peptide receptor: Relationship to smoking history and risk of lung cancer. J Natl Cancer Inst. 2000;92:24\u201333.", "ArticleIdList": ["10620630"]}, {"Citation": "Hollingsworth JW, et al. Ambient ozone primes pulmonary innate immunity in mice. J Immunol. 2007;179:4367\u20134375.", "ArticleIdList": ["17878331"]}, {"Citation": "Williams AS, et al. Role of p38 mitogen-activated protein kinase in ozone-induced airway hyperresponsiveness and inflammation. Eur J Pharmacol. 2008;600:117\u2013122.", "ArticleIdList": ["18926814"]}, {"Citation": "Voynow JA, et al. NAD(P)H quinone oxidoreductase 1 is essential for ozone-induced oxidative stress in mice and humans. Am J Respir Cell Mol Biol. 2009;41:107\u2013113.", "ArticleIdList": ["PMC2701957", "19059883"]}, {"Citation": "Baxter LT, Zhu H, Mackensen DG, Jain RK. Physiologically based pharmacokinetic model for specific and nonspecific monoclonal antibodies and fragments in normal tissues and human tumor xenografts in nude mice. Cancer Res. 1994;54:1517\u20131528.", "ArticleIdList": ["8137258"]}, {"Citation": "Mart\u00ednez A, Zudaire E, Juli\u00e1n M, Moody TW, Cuttitta F. Gastrin-releasing peptide (GRP) induces angiogenesis and the specific GRP blocker 77427 inhibits tumor growth in vitro and in vivo. Oncogene. 2005;24:4106\u20134113.", "ArticleIdList": ["15750618"]}, {"Citation": "Corjay MH, et al. Two distinct bombesin receptor subtypes are expressed and functional in human lung carcinoma cells. J Biol Chem. 1991;266:18771\u201318779.", "ArticleIdList": ["1655761"]}, {"Citation": "Williams BY, Wang Y, Schonbrunn A. Agonist binding and protein kinase C activation stimulate phosphorylation of the gastrin-releasing peptide receptor at distinct sites. Mol Pharmacol. 1996;50:716\u2013727.", "ArticleIdList": ["8863815"]}, {"Citation": "Chang LY, et al. A catalytic antioxidant attenuates alveolar structural remodeling in bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2003;167:57\u201364.", "ArticleIdList": ["12502477"]}, {"Citation": "Ally RA, et al. Agonist- and protein kinase C-induced phosphorylation have similar functional consequences for gastrin-releasing peptide receptor signaling via Gq. Mol Pharmacol. 2003;64:890\u2013904.", "ArticleIdList": ["14500746"]}, {"Citation": "De la Fuente M, Del Rio M, Ferrandez MD, Hernanz A. Modulation of phagocytic function in murine peritoneal macrophages by bombesin, gastrin-releasing peptide and neuromedin C. Immunology. 1991;73:205\u2013211.", "ArticleIdList": ["PMC1384466", "1649124"]}, {"Citation": "Lemaire I. Bombesin-related peptides modulate interleukin-1 production by alveolar macrophages. Neuropeptides. 1991;20:217\u2013223.", "ArticleIdList": ["1812404"]}, {"Citation": "Meloni F, et al. Bombesin enhances monocyte and macrophage activities: Possible role in the modulation of local pulmonary defenses in chronic bronchitis. Respiration. 1996;63:28\u201334.", "ArticleIdList": ["8833990"]}, {"Citation": "Csillag A, et al. Pollen-induced oxidative stress influences both innate and adaptive immune responses via altering dendritic cell functions. J Immunol. 2010;184:2377\u20132385.", "ArticleIdList": ["PMC3028537", "20118277"]}, {"Citation": "Polak JM, et al. Lung endocrine cell markers, peptides, and amines. Anat Rec. 1993;236:169\u2013171.", "ArticleIdList": ["8507003"]}, {"Citation": "Levine SJ, Wenzel SE. Narrative review: The role of Th2 immune pathway modulation in the treatment of severe asthma and its phenotypes. Ann Intern Med. 2010;152:232\u2013237.", "ArticleIdList": ["PMC2846792", "20157138"]}, {"Citation": "DeMichele MA, Davis AL, Hunt JD, Landreneau RJ, Siegfried JM. Expression of mRNA for three bombesin receptor subtypes in human bronchial epithelial cells. Am J Respir Cell Mol Biol. 1994;11:66\u201374.", "ArticleIdList": ["8018339"]}, {"Citation": "Finkelman FD, Hogan SP, Hershey GK, Rothenberg ME, Wills-Karp M. Importance of cytokines in murine allergic airway disease and human asthma. J Immunol. 2010;184:1663\u20131674.", "ArticleIdList": ["PMC4122090", "20130218"]}, {"Citation": "Dahl R. Systemic side effects of inhaled corticosteroids in patients with asthma. Respir Med. 2006;100:1307\u20131317.", "ArticleIdList": ["16412623"]}, {"Citation": "Chaudhry A, et al. Phase I and imaging trial of a monoclonal antibody directed against gastrin-releasing peptide in patients with lung cancer. Clin Cancer Res. 1999;5:3385\u20133393.", "ArticleIdList": ["10589749"]}, {"Citation": "Kelley MJ, et al. Antitumor activity of a monoclonal antibody directed against gastrin-releasing peptide in patients with small cell lung cancer. Chest. 1997;112:256\u2013261.", "ArticleIdList": ["9228385"]}, {"Citation": "Fischer JR, et al. Decrease of interleukin-2 secretion is a new independent prognostic factor associated with poor survival in patients with small-cell lung cancer. Ann Oncol. 1997;8:457\u2013461.", "ArticleIdList": ["9233525"]}, {"Citation": "Van Lommel A, Boll\u00e9 T, Fannes W, Lauweryns JM. The pulmonary neuroendocrine system: The past decade. Arch Histol Cytol. 1999;62:1\u201316.", "ArticleIdList": ["10223738"]}]}], "History": [{"Year": "2011", "Month": "1", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2011", "Month": "1", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2011", "Month": "3", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2011", "Month": "8", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["21252304", "PMC3033299", "10.1073/pnas.1014792108", "1014792108"]}}], "PubmedBookArticle": []}